iGan Partners

Sam Ifergan, President and CEO, leads investment decisions and maintains board representation across the portfolio. Ifergan founded the firm in 2012 following an earlier career as an angel investor and technology operator. The firm operates with a lean partnership structure where the investment committee process is tightly coupled with Ifergan's own investment judgment and operational involvement.

iGan relies heavily on Ifergan's long-standing network within the Toronto-Waterloo startup corridor and relationships with Canadian incubators and accelerators. The firm's reputation as a hands-on lead investor — rather than a passive capital provider — draws founder referrals from prior portfolio exits. It does not publicly disclose a formal scouting network or university partnership program, though its proximity to University of Toronto and University of Waterloo startup ecosystems is a structural input to sourcing.

iGan does not publicly list excluded sectors, but its investment record shows no activity in resource extraction, consumer packaged goods, retail, or traditional manufacturing. The firm's portfolio is consistently concentrated in B2B technology — enterprise software, cybersecurity, digital health, AI/ML, and IoT. Life sciences and drug development are notably absent from its deal history despite the broader digital health interest.

iGan operates independently in the Toronto venture ecosystem, without formal affiliations to larger platforms like OMERS Ventures, Georgian, or Real Ventures. The firm co-invests with peer funds on a transactional basis and maintains its own limited partner base. No spinout relationship exists with a prior institution — the firm was built from Ifergan's personal angel investing activity rather than as a breakaway vehicle from an established manager.